Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bushra Ijaz

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Journal of Translational Medicine|March 9, 2012
Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarrayWaqar Ahmad, Bushra Ijaz, Sajida Hassan
Journal of Molecular Graphics & Modelling|March 24, 2026
Inhibitory potential of Morus alba leaf extract and its phytoconstituent against SARS-CoV-2 main protease: An integrative in silico and in vitro analysisAyesha Malik, Sobia Noreen, Bushra Ijaz
Biochemical Genetics|December 19, 2023
LncRNA MALAT1 Expression Regulates Breast Cancer Progression via PI3K/AKT/mTOR Pathway ModulationMariam Naveed, Ayesha Malik, Hamza Anjum, et al.
Archives of Virology|July 8, 2017
Modulation of Wnt signaling pathway by hepatitis B virusMuhammad Daud, Muhammad Adeel Rana, Tayyab Husnain, et al.
Microbial Pathogenesis|May 19, 2018
Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cellsSidra Rehman, Usman Ali Ashfaq, Bushra Ijaz, et al.
Journal of Biomedical Science|September 21, 2017
Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/ RNS generationWaqar Ahmad, Bushra Ijaz, Khadija Shabbiri, et al.
Virology Journal|April 5, 2011
Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesisShah Jahan, Saba Khaliq, Bushra Ijaz, et al.
Natural Product Research|August 15, 2017
Epigallocatechin Gallate as an anti-obesity therapeutic compound: an in silico approach for structure-based drug designingMuhammad Shahid Javaid, Noreen Latief, Bushra Ijaz, et al.
Virology Journal|March 1, 2011
Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriersBushra Ijaz, Waqar Ahmad, Fouzia T Javed, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 12, 2016
Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico studySidra Rehman, Bushra Ijaz, Nighat Fatima, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Journal of Translational Medicine|March 9, 2012
Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarrayWaqar Ahmad, Bushra Ijaz, Sajida Hassan
Journal of Molecular Graphics & Modelling|March 24, 2026
Inhibitory potential of Morus alba leaf extract and its phytoconstituent against SARS-CoV-2 main protease: An integrative in silico and in vitro analysisAyesha Malik, Sobia Noreen, Bushra Ijaz
Biochemical Genetics|December 19, 2023
LncRNA MALAT1 Expression Regulates Breast Cancer Progression via PI3K/AKT/mTOR Pathway ModulationMariam Naveed, Ayesha Malik, Hamza Anjum, et al.
Archives of Virology|July 8, 2017
Modulation of Wnt signaling pathway by hepatitis B virusMuhammad Daud, Muhammad Adeel Rana, Tayyab Husnain, et al.
Microbial Pathogenesis|May 19, 2018
Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cellsSidra Rehman, Usman Ali Ashfaq, Bushra Ijaz, et al.
Journal of Biomedical Science|September 21, 2017
Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/ RNS generationWaqar Ahmad, Bushra Ijaz, Khadija Shabbiri, et al.
Virology Journal|April 5, 2011
Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesisShah Jahan, Saba Khaliq, Bushra Ijaz, et al.
Natural Product Research|August 15, 2017
Epigallocatechin Gallate as an anti-obesity therapeutic compound: an in silico approach for structure-based drug designingMuhammad Shahid Javaid, Noreen Latief, Bushra Ijaz, et al.
Virology Journal|March 1, 2011
Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriersBushra Ijaz, Waqar Ahmad, Fouzia T Javed, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 12, 2016
Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico studySidra Rehman, Bushra Ijaz, Nighat Fatima, et al.
Pageof 7